Muller-Oerlinghausen, B, Berghofer, A, Bauer, M. Bipolar disorder. Lancet
2002; 359: 241–7.
Bai, YM, Su, TP, Chen, MH, Chen, TJ, Chang, WH. Risk of developing diabetes mellitus and hyperlipidemia among patients with bipolar disorder, major depressive disorder, and schizophrenia: a 10-year nationwide population-based prospective cohort study. J Affect Disord
2013; 150: 57–62.
Lozano, R, Naghavi, M, Foreman, K, Lim, S, Shibuya, K, Aboyans, V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet
2012; 380: 2095–128.
Jane-Llopis, E, Matytsina, I. Mental health and alcohol, drugs and tobacco: a review of the comorbidity between mental disorders and the use of alcohol, tobacco and illicit drugs. Drug Alcohol Rev
2006; 25: 515–36.
Dreyer, L, Winther, JF, Andersen, A, Pukkala, E. Avoidable cancers in the Nordic countries. Alcohol consumption. APMIS Suppl
1997; 76: 48–67.
Dreyer, L, Winther, JF, Pukkala, E, Andersen, A. Avoidable cancers in the Nordic countries. Tobacco smoking. APMIS Suppl
1997; 76: 9–47.
Whitley, E, Batty, GD, Mulheran, PA, Gale, CR, Osborn, DP, Tynelius, P, et al. Psychiatric disorder as a risk factor for cancer: different analytic strategies produce different findings. Epidemiology
2012; 23: 543–50.
Dalton, SO, Mellemkjaer, L, Olsen, JH, Mortensen, PB, Johansen, C. Depression and cancer risk: a register-based study of patients hospitalized with affective disorders, Denmark, 1969-1993. Am J Epidemiol
2002; 155: 1088–95.
Beumer, W, Gibney, SM, Drexhage, RC, Pont-Lezica, L, Doorduin, J, Klein, HC, et al. The immune theory of psychiatric diseases: a key role for activated microglia and circulating monocytes. J Leukoc Biol
2012; 92: 959–75.
Tsai, SY, Chung, KH, Wu, JY, Kuo, CJ, Lee, HC, Huang, SH. Inflammatory markers and their relationships with leptin and insulin from acute mania to full remission in bipolar disorder. J Affect Disord
2012; 136: 110–6.
BarChana, M, Levav, I, Lipshitz, I, Pugachova, I, Kohn, R, Weizman, A, et al. Enhanced cancer risk among patients with bipolar disorder. J Affect Disord
2008; 108: 43–8.
McGinty, EE, Zhang, Y, Guallar, E, Ford, DE, Steinwachs, D, Dixon, LB, et al. Cancer incidence in a sample of Maryland residents with serious mental illness. Psychiatr Serv
2012; 63: 714–7.
Chen, YH, Lin, HC. Increased risk of cancer subsequent to severe depression–a nationwide population-based study. J Affect Disord
2011; 131: 200–6.
Rosenshfir, E, Shemesh, P, Aizenberg, D, Barak, Y. Reduced risk of cancer in patients with bipolar affective disorder. Neurosci & Med
2011; 2: 57–60.
Liang, JA, Sun, LM, Muo, CH, Sung, FC, Chang, SN, Kao, CH. The analysis of depression and subsequent cancer risk in Taiwan. Cancer Epidemiol Biomarkers Prev
2011; 20: 473–5.
Possel, P, Adams, E, Valentine, JC. Depression as a risk factor for breast cancer: investigating methodological limitations in the literature. Cancer Causes Control
2012; 23: 1223–9.
Tsai, SY, Yang, YY, Kuo, CJ, Chen, CC, Leu, SJ. Effects of symptomatic severity on elevation of plasma soluble interleukin-2 receptor in bipolar mania. J Affect Disord
2001; 64: 185–93.
Hsieh, MH, Tang, CH, Hung, ST, Lee, IH, Lin, YJ, Yang, YK. Comorbid prevalence of alcohol dependence, substance abuse, and external cause of injury in patients with bipolar disorder in a nationwide representative sample in Taiwan. Bipolar Disord
2012; 14: 677–9.
Bai, YM, Lin, CC, Hu, PG, Yeh, HS. Risk factors for substance use disorders among inpatients with major affective disorders in Taiwan Chinese. Gen Hosp Psychiatry
1998; 20: 377–80.
Gau, SS, Chao, PF, Lin, YJ, Chang, CJ, Gau, CS. The association between carbamazepine and valproate and adverse cutaneous drug reactions in patients with bipolar disorder: a nested matched case-control study. J Clin Psychopharmacol
2008; 28: 509–17.
World Health Organization. International Statistical Classification of Diseases and Related Health Problems (ICD–9). WHO, 1978.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Tobacco smoke and involuntary smoking. IARC Monogr Eval Carcinog Risks Hum
2004; 83: 1–1438.
Baan, R, Straif, K, Grosse, Y, Secretan, B, El Ghissassi, F, Bouvard, V, et al. Carcinogenicity of alcoholic beverages. Lancet Oncol
2007; 8: 292–3.
IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. Alcohol consumption and ethyl carbamate. IARC Monogr Eval Carcinog Risks Hum
2010; 96: 3–1383.
Woo, HD, Kim, J. Dietary flavonoid intake and smoking-related cancer risk: a meta-analysis. PLoS One
2013; 8: e75604.
Rothman, KJ, Greenland, S. Modern Epidemiology (2nd edn). Lippincott Williams & Wilkins, 1998.
Tang, CH, Hsieh, MH, Hung, ST, Lee, IH, Lin, YJ, Yang, YK. One-year post-hospital medical costs and relapse rates of bipolar disorder patients in Taiwan: a population-based study. Bipolar Disord
2010; 12: 859–65.
Vuorilehto, MS, Melartin, TK, Isometsa, ET. Course and outcome of depressive disorders in primary care: a prospective 18-month study. Psychol Med
2009; 39: 1697–707.
Heffner, JL, Strawn, JR, DelBello, MP, Strakowski, SM, Anthenelli, RM. The co?occurrence of cigarette smoking and bipolar disorder: phenomenology and treatment considerations. Bipolar Disord
2011; 13: 439–53.
Lasser, K, Boyd, JW, Woolhandler, S, Himmelstein, DU, McCormick, D, Bor, DH. Smoking and mental illness. JAMA
2000; 284: 2606–10.
Conway, KP, Compton, W, Stinson, FS, Grant, BF. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. J Clin Psychiatry
2006; 67: 247–57.
Wang, PW, Lin, HC, Yeh, YC, Liu, TL, Yen, CF. The relation of substance use with different levels of depressive symptoms and the moderating effect of sex and age in Taiwanese adolescents. Compr Psychiatry
2012; 53: 1013–20.
Oerlemans, ME, van den Akker, M, Schuurman, AG, Kellen, E, Buntinx, F. A meta-analysis on depression and subsequent cancer risk. Clin Pract Epidemiol Ment Health
2007; 3: 29.
Horwath, E, Weissman, MM. Epidemiology of depression and anxiety disorders. In Textbook in Psychiatric Epidemiology (eds Tsuang, MT, Tohen, M and Zahner, GEP): 317–44. Wiley-Liss, 1995.
Catts, V, Catts, S, O'toole, B, Frost, A. Cancer incidence in patients with schizophrenia and their first?degree relatives–a meta?analysis. Acta Psychiatr Scand
2008; 117: 323–36.
Lichtermann, D, Ekelund, J, Pukkala, E, Tanskanen, A, Lonnqvist, J. Incidence of cancer among persons with schizophrenia and their relatives. Arch Gen Psychiatry
2001; 58: 573.
Barak, Y, Achiron, A, Mandel, M, Mirecki, I, Aizenberg, D. Reduced cancer incidence among patients with schizophrenia. Cancer
2005; 104: 2817–21.
Hippisley-Cox, J, Vinogradova, Y, Coupland, C, Parker, C. Risk of malignancy in patients with schizophrenia or bipolar disorder: nested case-control study. Arch Gen Psychiatry
2007; 64: 1368–76.
Lin, GM, Chen, YJ, Kuo, DJ, Jaiteh, LE, Wu, YC, Lo, TS, et al. Cancer incidence in patients with schizophrenia or bipolar disorder: a nationwide population-based study in Taiwan, 1997–2009. Schizophr Bull
2013; 39: 407–16.
Chen, YJ, Wu, CY, Chen, TJ, Shen, JL, Chu, SY, Wang, CB, et al. The risk of cancer in patients with psoriasis: a population-based cohort study in Taiwan. J Am Acad Dermatol
2011; 65: 84–91.